IRS1, insulin receptor substrate 1, 3667

N. diseases: 233; N. variants: 15
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
phenotype Neoplastic Process 6626 169 0.100 None 1.000 11 2006 2019
Malignant neoplasm of colon and/or rectum
disease Neoplastic Process 3669 502 0.100 None 1.000 10 1 2004 2019
Oestrogen receptor positive breast cancer
disease Neoplastic Process 510 58 0.030 None 1.000 3 2001 2011
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia
disease Neoplastic Process 860 154 0.020 None 1.000 2 2017 2019
Obesity-Associated Insulin Resistance
disease Disease or Syndrome 36 0.020 None 1.000 2 2001 2018
estrogen receptor-negative breast cancer
disease Neoplastic Process 356 40 0.020 None 1.000 2 2008 2011
Low density lipoprotein cholesterol measurement
phenotype Laboratory Procedure 483 1142 0.100 None 1.000 1 1 2012 2012
CUI: C0342782
Disease: Depletion of mitochondrial DNA
Depletion of mitochondrial DNA
disease Disease or Syndrome 36 7 0.010 None 1.000 1 2011 2011
CUI: C0428474
Disease: Serum LDL cholesterol measurement
Serum LDL cholesterol measurement
phenotype Laboratory Procedure 269 555 0.100 None 1.000 1 1 2012 2012
body fat percentage (physical finding)
phenotype Finding 56 98 0.100 None 1.000 1 1 2017 2017
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
disease Disease or Syndrome 55 28 0.010 None 1.000 1 1 2009 2009
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
phenotype Disease or Syndrome 716 25 0.010 None 1.000 1 2004 2004
Differentiated Thyroid Gland Carcinoma
disease Neoplastic Process 245 80 0.010 None < 0.001 1 2014 2014
CUI: C1445957
Disease: Serum total cholesterol measurement
Serum total cholesterol measurement
phenotype Laboratory Procedure 486 1243 0.100 None 1.000 1 1 2012 2012
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
phenotype Neoplastic Process 1027 20 0.010 None 1.000 1 2012 2012
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
disease Finding 63 2 0.200 None 1.000 1 2011 2011
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
phenotype Finding 63 0.200 None 1.000 1 2011 2011
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
phenotype Finding 63 0.200 None 1.000 1 2011 2011
Obstructive sleep apnea hypopnea syndrome
disease Disease or Syndrome 41 7 0.010 None 1.000 1 1 2016 2016
CUI: C4529962
Disease: Fatty Liver Disease
Fatty Liver Disease
disease Disease or Syndrome 741 81 0.010 None < 0.001 1 2019 2019
Primary differentiated carcinoma of thyroid gland
disease Neoplastic Process 167 41 0.010 None < 0.001 1 2014 2014
CORONARY ARTERY DISEASE, SUSCEPTIBILITY TO
disease Finding 2 3 0.100 None 0 1
INSULIN RESISTANCE, SUSCEPTIBILITY TO
disease Finding 3 3 0.100 None 0 1
CUI: C4703555
Disease: Decreased waist to hip ratio
Decreased waist to hip ratio
phenotype Finding 28 0.100 None 0
CUI: C3887611
Disease: Restlessness
Restlessness
phenotype Behavior and Behavior Mechanisms Sign or Symptom 9 4 0.010 None 1.000 1 2015 2015